These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 9593116

  • 1. Prevention of infection due to Pneumocystis carinii.
    Fishman JA.
    Antimicrob Agents Chemother; 1998 May; 42(5):995-1004. PubMed ID: 9593116
    [No Abstract] [Full Text] [Related]

  • 2. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD, Bogner JR.
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of infection due to Pneumocystis carinii.
    Fishman JA.
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1309-14. PubMed ID: 9624465
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pneumocystis carinii pneumonia treatment in people infected with HIV.
    Bellamy R.
    Clin Evid; 2004 Jun; (11):935-50. PubMed ID: 15652046
    [No Abstract] [Full Text] [Related]

  • 6. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Castro M.
    Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
    [Abstract] [Full Text] [Related]

  • 7. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
    Korraa H, Saadeh C.
    South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
    [Abstract] [Full Text] [Related]

  • 8. Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
    Mallolas J, Zamora L, Gatell JM, Miró JM, Soriano E.
    Lancet; 1991 May 11; 337(8750):1162-3. PubMed ID: 1674036
    [No Abstract] [Full Text] [Related]

  • 9. Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
    James CW, McNelis KC, Szabo S.
    Am J Health Syst Pharm; 2003 Aug 01; 60(15):1572-4. PubMed ID: 12951757
    [No Abstract] [Full Text] [Related]

  • 10. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
    Edge MD, Rimland D.
    AIDS; 1999 May 28; 13(8):991-2. PubMed ID: 10371182
    [No Abstract] [Full Text] [Related]

  • 11. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
    Hughes WT, Killmar JT, Oz HS.
    J Infect Dis; 1994 Oct 28; 170(4):906-11. PubMed ID: 7930735
    [Abstract] [Full Text] [Related]

  • 12. Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients.
    Rodriguez M, Sifri CD, Fishman JA.
    Clin Infect Dis; 2004 Apr 15; 38(8):e76-8. PubMed ID: 15095235
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
    Deresinski SC.
    Semin Respir Infect; 1997 Jun 15; 12(2):79-97. PubMed ID: 9195673
    [Abstract] [Full Text] [Related]

  • 14. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.
    Helweg-Larsen J, Benfield T, Atzori C, Miller RF.
    J Antimicrob Chemother; 2009 Dec 15; 64(6):1282-90. PubMed ID: 19858161
    [Abstract] [Full Text] [Related]

  • 15. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M, Chau F, Simonpoli AM, Girard PM, Derouin F, Pocidalo JJ.
    J Infect Dis; 1994 Sep 15; 170(3):653-8. PubMed ID: 8077724
    [Abstract] [Full Text] [Related]

  • 16. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Tocchetti A, Tambini R, Allegro A, Longoni E, Rinaldi E.
    AIDS; 1994 Feb 15; 8(2):272-4. PubMed ID: 8043236
    [No Abstract] [Full Text] [Related]

  • 17. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
    Groll AH, Ritter J, Müller FM.
    Klin Padiatr; 2001 Sep 15; 213 Suppl 1():A38-49. PubMed ID: 11577363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.